Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 8, 2011, Pages 2515-2521

  Heffernan, Kevin S ^a   Kuvin, Jeffrey T ^a   Sarnak, Mark J ^a   Perrone, Ronald D ^a   Miskulin, Dana C ^a   Rudym, Darya ^a   Chandra, Priya ^a   Karas, Richard H ^a   Menon, Vandana ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

hypertension; inflammation; kidney disease; vascular function

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS ANTIGEN; FAS LIGAND; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; LABETALOL; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGE; ARTERY TONE; ARTICLE; AUGMENTATION INDEX; BODY HEIGHT; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC VASCULITIS;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; E-SELECTIN; FEMALE; GLOMERULAR FILTRATION RATE; HEART RATE; HUMANS; HYPERTENSION; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; P-SELECTIN; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROGNOSIS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR DISEASES;

EID: 79961082181     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq806     Document Type: Article

References (54)

1. Perrone RD, Ruthazer R, Terrin NC. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis 2001;38:777-784
2. Ecder T, Schrier RW. Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol 2001;12:194-200 (Pubitemid 32056806)
3. Covic A, Haydar AA, Bhamra-Ariza P et al. Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol 2005;18:388-396 (Pubitemid 41700101)
4. Filiopoulos V, Vlassopoulos D. Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. Inflamm Allergy Drug Targets 2009;8:369-382
5. Mitchell GF, Wang N, Palmisano JN et al. Hemodynamic correlates of blood pressure across the adult age spectrum: noninvasive evaluation in the framingham heart study. Circulation 2010;122:1379-1386.
6. Sesso HD, Buring JE, Rifai N et al. C-reactive protein and the risk of developing hypertension. JAMA 2003;290:2945-2951 (Pubitemid 37505526)
7. Taal MW, Sigrist MK, Fakis A et al. Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5. Nephron Clin Pract 2007;107:c177-c181
8. Takenaka T, Mimura T, Kanno Y et al. Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases. Am J Nephrol 2005;25:417-424 (Pubitemid 41433884)
9. Tonelli M, Sacks F, Pfeffer M et al. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 2005;68:237-245 (Pubitemid 43181381)
10. London GM, Blacher J, Pannier B et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001;38:434-438 (Pubitemid 34225679)
11. Menon V, Greene T, Wang X et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005;68:766-772 (Pubitemid 43323132)
12. Heffernan KS, Patvardhan EA, Hession M et al. Elevated augmentation index derived from peripheral arterial tonometry is associated with abnormal ventricular-vascular coupling. Clin Physiol Funct Imaging 2010;30:313-317
13. Heffernan KS, Sharman JE, Yoon ES et al. Effect of increased preload on the synthesized aortic blood pressure waveform. J Appl Physiol 2010;109:484-490
14. Nishiura R, Kita T, Yamada K et al. Radial augmentation index is related to cardiovascular risk in hemodialysis patients. Ther Apher Dial 2008;12:157-163 (Pubitemid 351490251)
15. Tsioufis C, Tzioumis C, Marinakis N et al. Microalbuminuria is closely related to impaired arterial elasticity in untreated patients with essential hypertension. Nephron Clin Pract 2003;93:c106-c111
16. London GM, Guerin AP, Marchais SJ et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996;50:600-608 (Pubitemid 26274391)
17. Marchais SJ, Guerin AP, Pannier BM et al. Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension 1993;22:876-883 (Pubitemid 23358096)
18. Borresen ML, Wang D, Strandgaard S. Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function. Am J Nephrol 2007;27:240-246 (Pubitemid 47164672)
19. Lieb W, Larson MG, Benjamin EJ et al. Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation 2009;119:37-43
20. Schnabel R, Larson MG, Dupuis J et al. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension 2008;51:1651-1657
21. Merta M, Tesar V, Zima T et al. Cytokine profile in autosomal dominant polycystic kidney disease. Biochem Mol Biol Int 1997;41:619-624 (Pubitemid 27154142)
22. Chapman AB, Torres VE, Perrone RD et al. The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol; 2010;5:102-109
23. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470 (Pubitemid 29135798)
24. Heffernan KS, Karas RH, Patvardhan EA et al. Peripheral arterial tonometry for risk stratification in men with coronary artery disease. Clin Cardiol 2010;33:94-98
25. Kuvin JT, Patel AR, Sliney KA et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003;146:168-174 (Pubitemid 36851317)
26. Millasseau SC, Guigui FG, Kelly RP et al. Noninvasive assessment of the digital volume pulse. Comparison with the peripheral pressure pulse. Hypertension 2000;36:952-956
27. Kelly R, Hayward C, Avolio A et al. Noninvasive determination of age-related changes in the human arterial pulse. Circulation 1989;80:1652-1659 (Pubitemid 20031695)
28. Takazawa K, Tanaka N, Takeda K et al. Underestimation of vasodilator effects of nitroglycerin by upper limb blood pressure. Hypertension 1995;26:520-523
29. Nurnberger J, Keflioglu-Scheiber A, Opazo Saez AM et al. Augmentation index is associated with cardiovascular risk. J Hypertens 2002;20:2407-2414 (Pubitemid 36026853)
30. van Trijp MJ, Bos WJ, Uiterwaal CS et al. Determinants of augmentation index in young men: the ARYA study. Eur J Clin Invest 2004;34:825-830 (Pubitemid 39657929)
31. Smulyan H, Marchais SJ, Pannier B et al. Influence of body height on pulsatile arterial hemodynamic data. J Am Coll Cardiol 1998;31:1103-1109 (Pubitemid 28212513)
32. Wilkinson IB, MacCallum H, Flint L et al. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000;525 Pt 1:263-270 (Pubitemid 30311951)
33. Wilkinson IB, Mohammad NH, Tyrrell S et al. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002;15:24-30 (Pubitemid 34102268)
34. Fantin F, Mattocks A, Bulpitt CJ et al. Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing 2007;36:43-48 (Pubitemid 47072032)
35. McEniery CM, Yasmin Hall IR et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005;46:1753-1760 (Pubitemid 41531635)
36. Mitchell GF, Parise H, Benjamin EJ et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004;43:1239-1245 (Pubitemid 38691746)
37. Clausen P, Feldt-Rasmussen B, Iversen J et al. Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease. Am J Nephrol 2006;26:335-339 (Pubitemid 44394151)
38. Hogas SM, Voroneanu L, Serban DN et al. Methods and potential biomarkers for the evaluation of endothelial dysfunction in chronic kidney disease: a critical approach. J Am Soc Hypertens 2010;4:116-127
39. Stam F, van Guldener C, Schalkwijk CG et al. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 2003;18:892-898 (Pubitemid 36592529)
40. Sato M, Konuma T, Yanagisawa N et al. Fas-Fas ligand system in the peripheral blood of patients with renal diseases. Nephron 2000;85:107-113 (Pubitemid 30330532)
41. Woo D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 1995;333:18-25
42. Kampus P, Muda P, Kals J et al. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol 2006;112:46-51 (Pubitemid 44247175)
43. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005;46:1118-1122 (Pubitemid 41533013)
44. Booth AD, Wallace S, McEniery CM et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004;50:581-588 (Pubitemid 38198843)
45. Verbeke F, Van Biesen W, Peeters P et al. Arterial stiffness and wave reflections in renal transplant recipients. Nephrol Dial Transplant 2007;22:3021-3027 (Pubitemid 350093449)
46. Kanbay M, Afsar B, Gusbeth-Tatomir P et al. Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol 2010;42:741-752
47. Azurmendi PJ, Fraga AR, Galan FM et al. Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function. Nephrol Dial Transplant 2009;24:2458-2463
48. Latham RD, Rubal BJ, Westerhof N et al. Nonhuman primate model for regional wave travel and reflections along aortas. Am J Physiol 1987;253:H299-H306
49. Latham RD, Westerhof N, Sipkema P et al. Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures. Circulation 1985;72:1257-1269 (Pubitemid 16126806)
50. Segers P, Verdonck P. Role of tapering in aortic wave reflection: hydraulic and mathematical model study. J Biomech 2000;33:299-306
51. Torres VE, King BF, Chapman AB et al. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2007;2:112-120
52. Levine E, Grantham JJ. Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients. AJR Am J Roentgenol 1992;159:77-81
53. Haydar AA, Covic A, Colhoun H et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 2004;65:1790-1794 (Pubitemid 38591027)
54. Barrett BJ, Foley R, Morgan J et al. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. Kidney Int 1994;46:1118-1123 (Pubitemid 24319951)